Regeneron Pharmaceuticals Inc. buy The Goldman Sachs Group, Inc.
Start price
30.04.25
/
50%
€524.00
Target price
30.04.26
€707.12
Performance (%)
25.09%
Price
11:29
€651.90
This prediction will end soon
Summary
This prediction is currently active. The prediction currently has a performance of 25.09%. A total of €3.58 was paid as dividends for this prediction. This prediction currently runs until 30.04.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Regeneron Pharmaceuticals Inc. | 3.538% | 3.538% |
| iShares Core DAX® | -0.201% | 5.471% |
| iShares Nasdaq 100 | 2.573% | 10.092% |
| iShares Nikkei 225® | 0.598% | 9.871% |
| iShares S&P 500 | 1.804% | 7.404% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $917.00 to $804.00. They now have a "buy" rating on the stock.
Ratings data for REGN provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€500.00
14.04.25
14.04.25
€805.31
14.04.26
14.04.26
27.38%
15.04.26
15.04.26
